The head of the U.S. Food and Drug Administration is considering using the agency’s powers to bring more price competition to the market for generic drugs, targeting high-priced products by
She drew the life-saving medication into the syringe, just 10cc of colorless fluid for the everyday low price of, gulp, several hundred dollars. Was that a new chemotherapy, specially designed
New legislation increases the speed of the FDA approval process for generics by introducing fees for applying manufacturers. This is not a new approach manufacturers have been paying application
The nation could have saved an estimated $73 billion from 2010 to 2012 if clinicians had more frequently prescribed alternatives to brand-name drugs, a JAMA Internal Medicine study finds. The
Founded by brothers Geoffrey and Matthew Chaiken, Blink Health is changing lives in just a few easy steps. Once you’ve received a prescription from your doctor and sent it to
It’s not often that investors get an opportunity to invest in a whole new class of drugs, but they’ve got an opportunity to invest on the ground floor with biosimilars.
Over the last several years, patent cliffs have led to steep revenue losses for traditional pharmaceuticals as well as created a gateway for smaller companies to come to market with
Our population is aging and more people than ever are taking prescription drugs, contributing to the rising costs of health care. Consumers, insurance companies, and governments are all helping to
Generic drugs, normally a bargain alternative to name-brand pharmaceuticals, are providing some sticker shock of their own. Prices of generic drugs rose more steeply than inflation for 22 percent of
A small team of drug industry veterans in Grafton, MA, has launched a nonprofit startup to make affordable generic medicines to treat critical diseases. “We want to create a competitor
